Istanbul University

istanbul.edu.tr

Matched: Istanbul University - Cerrahpasa · Istanbul University

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

1,141

Active

247

Phase 3

6

Total enrollment

121,013

Pipeline matrix

Showing 14 of 14 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Indocyanine Green1
In this study, morphine administration, which is routinely and frequently used in our operating room for patients undergoing CABG, was applied as an additional intervention1
Botulinum toxin1
Botulinum toxin + Occlusal splint combined1
Betamethasone2
tubular bandage1
BIS-guided propofol sedation1
Clinical-guided propofol sedation1
Losartan1
Normal Saline1
Midalozam1
Fentanyl1
Oral Elemental Iron (Ferrous Sulfate) 80 mg/day1
Steroid-Lidocaine1

Next readouts

  • 2024-09-30
  • 2026-01-01
  • 2026-05-01
  • 2026-05-30
  • 2026-06-15
  • 2026-07
  • 2026-09-01
  • 2026-11
  • 2027-04
  • 2027-09-01

Top conditions

  • Pain22
  • Anesthesia20
  • Pain, Postoperative17
  • Postoperative Pain17
  • Stroke16
  • Multiple Sclerosis16
  • Exercise13
  • Cerebral Palsy13

Frequently asked questions about Istanbul University

How many clinical trials does Istanbul University have on ClinicalTrials.gov?
Istanbul University is listed as the lead sponsor on 1,141 clinical trials in ClinicalTrials.gov, 247 of which are currently active (recruiting, enrolling, or ongoing).
How many of Istanbul University's trials are in Phase 3?
6 of Istanbul University's trials are in Phase 3, spread across 14 active drug programs.
What therapeutic areas does Istanbul University focus on?
Istanbul University's most-studied conditions on ClinicalTrials.gov are Pain, Anesthesia, Pain, Postoperative, Postoperative Pain, Stroke.
When are Istanbul University's next clinical trial readouts?
Istanbul University has 10 upcoming primary-completion readouts tracked here; the soonest is “Effect of Tubular Bandage Application on Peripheral Intravenous Catheter Usage Time and Infiltration in Children”, expected around 2024-09-30.